Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The immunomodulatory mechanism of dexmedetomidine

International Immunopharmacology(2021)10.1016/j.intimp.2021.107709Source: DataRank Database

The immunomodulatory mechanism of dexmedetomidine is a research paper published in International Immunopharmacology (2021). On theSindex it has a DataRank of 0. It has been cited 64 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access64 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 6.94)OA: greenTopics (37)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (1)

Koichi Yuki ORCID

Live enrichment

PubMed:33933842 PMC:PMC8324520 OpenAlex:https://openalex.org/W3157038629

National Institute of General Medical Sciences

Grant: GM118277/GM127600

NIGMS NIH HHS

Grant: R01 GM118277

NIGMS NIH HHS

Grant: R01 GM127600

National Institutes of Health

FWCI

6.94

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8324520

publisherhttps://api.elsevier.com/content/article/PII:S1567576921003453?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1567576921003453?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.intimp.2021.107709

Fields of Study

Cancer, Stress, Anesthesia, and Immune ResponseAnesthesia and Sedative AgentsAnesthesia and Neurotoxicity ResearchAdrenergic alpha-2 Receptor AgonistsAnimalsDexmedetomidineDisease Models, AnimalHumansImmunologic FactorsInflammation MediatorsLeukocytesPerioperative PeriodReceptors, Adrenergic, alpha-2Stress, PhysiologicalSurgical Procedures, Operative

MeSH Terms

AnimalsDisease Models, AnimalHumansImmunologic FactorsLeukocytesStress, PhysiologicalSurgical Procedures, OperativeReceptors, Adrenergic, alpha-2Inflammation MediatorsDexmedetomidineAdrenergic alpha-2 Receptor AgonistsPerioperative Period

Keywords

DexmedetomidineMedicinePerioperativeImmune systemAnesthesiaIntensive care medicineImmunologySedationLeukocyteOutcome

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of Dexmedetomidine reduces myocardial ischemia-reperfusion injury in young mice through MIF/AMPK/GLUT4 axis

10.6084/m9.figshare.21117575.v1figshare

Additional file 1 of Dexmedetomidine reduces myocardial ischemia-reperfusion injury in young mice through MIF/AMPK/GLUT4 axis

10.6084/m9.figshare.21117575figshare

The immunomodulatory mechanism of dexmedetomidine

FAIR Checklist

Authors (1)

Funding (4 grants)

Impact

Open Access

Topics

Linked Datasets (2)

Annotations (Europe PMC)